Metraipolis › archive › dc_5e2a285233ec

Biologic Therapy and Malignancy Risk in Psoriasis: A Retrospective Cohort Study — Europe PMC PMID:40922413

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40922413
DOI
10.1111/1346-8138.17950
License (as archived)
solo-consultazione
Archived
2026-11-10T01:51:33.856Z
SHA-256 of the archived text
2c6a169c087a4a2409362998d3c2c204988790bc08a144cd4711dc9504b8e73a
Stable URL of this page
https://metraipolis.com/documento/dc_5e2a285233ec

How to cite

Biologic Therapy and Malignancy Risk in Psoriasis: A Retrospective Cohort Study — Europe PMC PMID:40922413 — Europe PMC (en), https://europepmc.org/article/MED/40922413 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5e2a285233ec (Metraipolis archive dc_5e2a285233ec, sha256 2c6a169c087a4a2409362998d3c2c204988790bc08a144cd4711dc9504b8e73a)
BibTeX
@misc{dc5e2a285233ec,
  title = {Biologic Therapy and Malignancy Risk in Psoriasis: A Retrospective Cohort Study — Europe PMC PMID:40922413},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40922413},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5e2a285233ec; sha256 2c6a169c087a4a2409362998d3c2c204988790bc08a144cd4711dc9504b8e73a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40922413. Agents can read the archived copy with the MCP tool read_document.